Last $1.86 USD
Change Today 0.00 / 0.00%
Volume 13.6K
VRML On Other Exchanges
As of 3:51 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John P. Cooke M.D.,  Ph.D.

Former Member of Scientific Advisory Board, Vermillion, Inc.
AgeTotal Calculated CompensationThis person is connected to 50 board members in 3 different organizations across 5 different industries.

See Board Relationships


Dr. John P. Cooke, M.D., Ph.D. is a Professor in the Division of Cardiovascular Medicine, and Associate Director (Education and Training) of the Stanford Cardiovascular Institute at Stanford University School of Medicine. At Stanford, Dr. Cooke spearheads the programme in Vascular Biology and Medicine and directs a translational research programme in vascular biology from molecule to man, focused on endothelial biology, angiogenesis and vascular regeneration. He is a ...

Read Full Background

Corporate Headquarters*

Building III
Austin, Texas 78738

United States

Phone: 512-519-0400
Fax: 512-439-6980

Board Members Memberships*

There is no Board Members Memberships data available.


Wayne State University
Unknown/Other Education
Mayo Clinic College of Medicine
Mayo Graduate School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRML:US $1.86 USD 0.00


Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
John A. Scarlett M.D.Chief Executive Officer, President and Director
Geron Corporation
Paul K. Wotton Ph.D.Chief Executive Officer, President, Director and Member of Pricing Committee
Ocata Therapeutics, Inc.
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, General Counsel and Director
Neuralstem, Inc.
Andrey Semechkin Ph.D.Co-Chairman and Chief Executive Officer
International Stem Cell Corporation
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERMILLION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at